Belldegrun Arie
Director · Allogene Therapeutics, Inc.
Every open-market stock purchase Belldegrun Arie has reported to the SEC on Form 4 that met our signal bar, parsed straight from the filings. This page tracks where how the prices paid compare to where the stock trades now.
Where the buys stand today
- ALLOAllogene Therapeutics, Inc.
One purchase totalling $5.0M at an average of $2.90 per share. See all insider buying in ALLO →
Avg price paid$2.90Latest price—Market capUnknown
All reported buys
Follow new qualifying clusters involving Belldegrun Arie or other insiders
Explore qualifying clusters from public SEC filings. Pro adds email and Telegram notifications after detection.
About this data
Figures are parsed from Belldegrun Arie's Form 4 filings on SEC EDGAR (CIK 1296549) and cover open-market purchases (transaction code P) — grants, option exercises, and sales are excluded, which is why totals here can differ from raw filing counts. Every row links to its source document.
This page is informational and reflects public filing data. It is not investment advice.